Clinical utility of C-reactive protein to predict treatment response during cystic fibrosis pulmonary exacerbations.
<h4>Rationale</h4>C-reactive protein (CRP) is a systemic marker of inflammation that correlates with disease status in cystic fibrosis (CF). The clinical utility of CRP measurement to guide pulmonary exacerbation (PEx) treatment decisions remains uncertain.<h4>Objectives</h4>...
Saved in:
| Main Authors: | Ashutosh Sharma, Gordon Kirkpatrick, Virginia Chen, Kate Skolnik, Zsuzsanna Hollander, Pearce Wilcox, Bradley S Quon |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2017-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0171229&type=printable |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Plasma sCD14 as a biomarker to predict pulmonary exacerbations in cystic fibrosis.
by: Bradley S Quon, et al.
Published: (2014-01-01) -
A new Era of Personalized Medicine for Cystic Fibrosis – at Last!
by: Bradley S Quon, et al.
Published: (2015-01-01) -
Evaluation of Copeptin during Pulmonary Exacerbation in Cystic Fibrosis
by: I. Wojsyk-Banaszak, et al.
Published: (2019-01-01) -
Optic Disc Swelling and Vision Loss in a Patient with Cystic Fibrosis and Diabetes
by: Ioulia Iosfina, et al.
Published: (2013-01-01) -
Vancomycin Monitoring for Treatment of Acute Pulmonary Exacerbations of Adult Cystic Fibrosis Patients
by: Darrell Smith, et al.
Published: (2025-01-01)